Drug Profile
Betamethasone valerate foam - Foamix
Alternative Names: Betamethasone 0.12% emollient foam - Foamix; BetMetFoam Emollient; BetMetFoam Oily; BetMetFoam WaterlessLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Foamix
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Fluorinated steroids; Glucocorticoids; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Atopic dermatitis; Psoriasis
Highest Development Phases
- Phase II Atopic dermatitis; Psoriasis
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 20 Aug 2015 Phase-II development is ongoing for atopic dermatitis and psoriasis in Israel
- 02 May 2013 Phase-II development is ongoing in Israel